Clinical Trials on Moderate or Severe Coma in United Kingdom
Total 385 results
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessAustralia, Canada, United Kingdom
-
Kythera BiopharmaceuticalsCompletedPhase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat (ATX-101)Moderate or Severe Submental FullnessUnited Kingdom, Canada, Australia
-
Kythera BiopharmaceuticalsBayerCompletedModerate or Severe Submental FullnessBelgium, France, Germany, Italy, Spain, United Kingdom
-
Kythera BiopharmaceuticalsBayerCompletedModerate or Severe Submental FullnessGermany, France, Belgium, Spain, United Kingdom
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States, Canada
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States, Canada
-
Astellas Pharma Europe Ltd.CompletedModerate to Severe Vasomotor SymptomsUnited Kingdom
-
Manchester University NHS Foundation TrustCardiff University; University of Manchester; National Institute for Health Research... and other collaboratorsCompletedModerate or Severe Vision Impairment, Both EyesUnited Kingdom
-
Beer, Kenneth R., M.D., PAMedicis Pharmaceutical CorporationCompletedMild to Moderate Temporal Atrophy | Moderate to Severe Glabellar Rhytids | Moderate to Severe Periorbital RhytidsUnited States
-
AllerganCompletedModerate to Severe Nasolabial FoldsUnited States
-
Royal College of MusicCompletedIndividuals Experiencing Mild or Moderate Mental Health IssuesUnited Kingdom
-
AllerganCompletedPatients With Moderate to Severe Perioral LinesUnited States
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States, Canada
-
Merz Aesthetics GmbHMerz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States, Germany
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States
-
Croma-Pharma GmbHActive, not recruitingModerate to Severe Midface Volume DeficitUnited States
-
University of NottinghamNottinghamshire Healthcare NHS TrustNot yet recruitingMajor Depressive Disorder | Depression Moderate | Depression SevereUnited Kingdom
-
PfizerTerminatedModerate-severe PainUnited States
-
Royal Victoria InfirmaryBritish Skin FoundationCompletedModerate to Severe Atopic EczemaUnited Kingdom
-
Kythera BiopharmaceuticalsCompletedEfficacy | Safety | Moderate to Severe Convexity of Submental FatUnited States
-
PfizerTerminatedModerate-severe PainUnited States
-
Kythera BiopharmaceuticalsCompletedEfficacy | Safety | Moderate to Severe Convexity of Submental FatUnited States
-
PfizerCompleted
-
King's College LondonUnknownModerate to Severe Alzheimer's DiseaseUnited Kingdom
-
Merz North America, Inc.CompletedCorrection of Moderate to Severe Nasolabial FoldsUnited States
-
QRxPharma Inc.CompletedAcute Moderate to Severe PainUnited States
-
Medivation, Inc.PfizerTerminatedModerate to Severe AlzheimerChile, United Kingdom
-
Novartis PharmaceuticalsCompletedModerate and Severe Plaque PsoriasisUnited States, Argentina, Germany, Belgium, Italy, United Kingdom, Turkey, Guatemala, Australia
-
BioPharmX, Inc.CompletedModerate to Severe Papulopustular RosaceaUnited States
-
GenfitCompletedLiver Diseases | Moderate Hepatic Impairment | Severe Hepatic ImpairmentUnited States
-
Lindner Center of HOPEUniversity of Cincinnati; AbbottCompletedBipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild ManiaUnited States
-
Grünenthal GmbHDepomedTerminatedModerate to Severe Acute Postoperative PainUnited States, United Kingdom, Poland
-
University of SheffieldCompletedLong-term Physical Health Conditions | Mild to Moderate Anxiety and/or DepressionUnited Kingdom
-
Novartis PharmaceuticalsCompletedModerate to Severe Nail PsoriasisGermany, Belgium, Spain, United States, Australia, United Kingdom, Denmark, Czechia, Greece
-
Actavis Inc.CompletedModerate to Severe Papulopustular RosaceaUnited States
-
Great Ormond Street Hospital for Children NHS Foundation...Imperial College London; Barts & The London NHS Trust; Intensive Care National...CompletedFIRST-line Support for Assistance in Breathing in Children (FIRST-ABC) Feasibility Study (FIRST-ABC)Hypoxia | Respiratory Acidosis | Moderate/Severe Respiratory DistressUnited Kingdom
-
Wake Forest University Health SciencesCompleted
-
Egalet LtdCompletedModerate-to-severe Chronic Noncancer PainUnited States
-
Bristol-Myers SquibbCompletedModerate Liver Impairment | Severe Liver ImpairmentUnited States
-
PfizerRecruitingHealthy Volunteers | Moderate Hepatic Impairment | Severe Hepatic ImpairmentUnited States
-
AbbottCompletedModerate to Severe Chronic, Non-malignant PainUnited States
-
Braeburn PharmaceuticalsCompleted
-
Tufts Medical CenterCentocor, Inc.CompletedModerate to Severe Palmar Plantar PsoriasisUnited States
-
University of California, San FranciscoCompletedModerate to Severe PsoriasisUnited States
-
UCB Biopharma SRLActive, not recruitingModerate to Severe Plaque PsoriasisUnited States, Canada, Germany, Poland
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque PsoriasisUnited States
-
Actavis Inc.Watson Laboratories, Inc.CompletedBACTERIAL VAGINOSIS | Signs and Symptoms to be Evaluated and Recorded Include | Vaginal Discharge Color, Odor, and Consistency | Vulvovaginal Itching and Irritation (Subjective) Absent, Mild, Moderate, or Severe | Vulvovaginal Inflammation (Objective) Absent, Mild, Moderate, or SevereUnited States, Dominican Republic, Puerto Rico